Cargando…

C-Type Natriuretic Peptide Ameliorates Lipopolysaccharide-Induced Cardiac Dysfunction in Rats with Pulmonary Arterial Hypertension

Lipopolysaccharide induces rapid deterioration of cardiac function in rats with pulmonary arterial hypertension. It was desired to investigate if this cardiac dysfunction could be treated by C-type natriuretic peptide. Rat pulmonary arterial hypertension was induced by intraperitoneal injection of m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Xiaowei, Zhu, Maoen, Cao, Yanan, Yang, Yue, Ye, Zhi, Zhang, Fan, Guo, Qulian, Peng, Yonggang, Wang, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317089/ https://www.ncbi.nlm.nih.gov/pubmed/30671449 http://dx.doi.org/10.1155/2018/2813025

Ejemplares similares

Lipopolysaccharide acutely suppresses right-ventricular strain in rats with pulmonary artery hypertension
por: Zhang, Junjie, et al.
Publicado: (2017)

Sevoflurane inhibits cardiac function in pulmonary fibrosis mice through the TLR4 signaling pathway
por: Cao, Yanan, et al.
Publicado: (2018)

Constitutively active form of natriuretic peptide receptor 2 ameliorates experimental pulmonary arterial hypertension
por: Nawa, Nobutoshi, et al.
Publicado: (2016)

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk
por: Sarzani, Riccardo, et al.
Publicado: (2017)

Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent
por: Casserly, Brian, et al.
Publicado: (2009)

Manipulating the natriuretic peptide system for the treatment of pulmonary hypertension
por: Baliga, Reshma S, et al.
Publicado: (2009)

Reduced immunoreactivities of B-type natriuretic peptide in pulmonary arterial hypertension rats after ranolazine treatment
por: Lee, Jae Chul, et al.
Publicado: (2016)

Augmented expression of cardiac atrial natriuretic peptide system in hypertensive rats.
por: An, M. R., et al.
Publicado: (1999)

Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
por: Werner, Franziska, et al.
Publicado: (2016)

Plasma MIR-212-3p as a biomarker for acute right heart failure with pulmonary artery hypertension
por: Yang, Yue, et al.
Publicado: (2020)

Natriuretic Peptides in Assessment of Ventricular Dysfunction
por: Gorenjak, Maksimiljan
Publicado: (2003)

Human genetics, natriuretic peptides and hypertension
por: Newton-Cheh, Christopher
Publicado: (2011)

C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice
por: Kimura, Toru, et al.
Publicado: (2016)

Metabonomics Analysis of Myocardial Metabolic Dysfunction in Patients with Cardiac Natriuretic Peptide Resistance
por: Chang, Pan, et al.
Publicado: (2020)

Correction to: Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
por: Werner, Franziska, et al.
Publicado: (2022)

The Utility of Brain Natriuretic Peptide in Patients Undergoing an Initial Evaluation for Pulmonary Hypertension
por: Rao, Sanjana, et al.
Publicado: (2022)

Erratum to: C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice
por: Kimura, Toru, et al.
Publicado: (2016)

Comparison of Brain Natriuretic Peptide Levels to Simultaneously Obtained Right Heart Hemodynamics in Stable Outpatients with Pulmonary Arterial Hypertension
por: Helgeson, Scott A., et al.
Publicado: (2018)

The Association of N-Terminal Pro-Brain Natriuretic Peptide With Time to Clinical Worsening in Hispanic Patients With Pulmonary Arterial Hypertension
por: Khatab, Yacoub, et al.
Publicado: (2022)

C-type natriuretic peptide prevents angiotensin II-induced cardiac remodelling and dysfunction
por: Roloff, Konstanze, et al.
Publicado: (2015)

Acid ceramidase gene therapy ameliorates pulmonary arterial hypertension with right heart dysfunction
por: Katz, Michael G., et al.
Publicado: (2023)

N-terminal pro-brain natriuretic peptide levels in patients with anomalous left coronary artery from pulmonary artery
por: Yunfei, Ling, et al.
Publicado: (2020)

Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with cardiovascular death, postoperative cardiac, renal and pulmonary dysfunction
por: Hajjar, L, et al.
Publicado: (2008)

Long non-coding RNA expression profiling in the lungs of pulmonary arterial hypertension rats with acute inflammation
por: Yang, Yue, et al.
Publicado: (2019)

Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction
por: Luers, Claus, et al.
Publicado: (2010)

The Role of Natriuretic Peptides for the Diagnosis of Left Ventricular Dysfunction
por: Palazzuoli, Alberto, et al.
Publicado: (2013)

Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage
por: Garcia-Alvarez, Ana, et al.
Publicado: (2010)

Differential effects of atrial and brain natriuretic peptides on human pulmonary artery: An in vitro study
por: Hussain, Azar, et al.
Publicado: (2019)

Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis
por: Baliga, R S, et al.
Publicado: (2014)

Purinergic Dysfunction in Pulmonary Arterial Hypertension
por: Cai, Zongye, et al.
Publicado: (2020)

Mitochondrial dysfunction in pulmonary arterial hypertension
por: Zhang, Weiwei, et al.
Publicado: (2022)

Role of Cardiac Natriuretic Peptides in Heart Structure and Function
por: Sarzani, Riccardo, et al.
Publicado: (2022)

Fasudil Dichloroacetate Alleviates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension by Ameliorating Dysfunction of Pulmonary Arterial Smooth Muscle Cells
por: Liu, Ping, et al.
Publicado: (2021)

C-type natriuretic peptide and natriuretic peptide receptor B signalling inhibits cardiac sympathetic neurotransmission and autonomic function
por: Buttgereit, Jens, et al.
Publicado: (2016)

Lymphangiogenic therapy prevents cardiac dysfunction by ameliorating inflammation and hypertension
por: Song, LouJin, et al.
Publicado: (2020)

Sex Differences in the Beneficial Cardiac Effects of Chronic Treatment with Atrial Natriuretic Peptide In Spontaneously Hypertensive Rats
por: Romero, Mariana, et al.
Publicado: (2013)

C-type natriuretic peptide chronic administration attenuates cardiac fibrosis and inflammation in spontaneously hypertensive rats
por: Prentki, E Santos, et al.
Publicado: (2015)

Cardiac Natriuretic Peptide Profiles in Chronic Hypertension by Single or Sequentially Combined Renovascular and DOCA-Salt Treatments
por: Cerrudo, Carolina S., et al.
Publicado: (2021)

Association of brain natriuretic peptide gene polymorphisms with chronic obstructive pulmonary disease complicated with pulmonary hypertension and its mechanism
por: Jin, Guangjun, et al.
Publicado: (2018)

Elevated pulmonary artery pressure and brain natriuretic peptide in high altitude pulmonary edema susceptible non-mountaineers
por: Gupta, Rajinder K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ef2pld2e8t91dpschek73tuc7k